1. |
Kanemoto K, Tadokoro Y, Oshima T. Psychotic illness in patients with epilepsy. Ther Adv Neurol Disord, 2012, 5(6): 321-334.
|
2. |
Vinti V, Dell'Isola GB, Tascini G, et al. Temporal Lobe Epilepsy and Psychiatric Comorbidity. Front Neurol, 2021, 30,12: 775781.
|
3. |
Hingray C, McGonigal A, Kotwas I, et al. The relationship between epilepsy and anxiety disorders. Curr Psychiatry Rep. 2019, 21(6): 40.
|
4. |
Vezzani A, Balosso S, Ravizza T. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol, 2019, 15(8): 459-472.
|
5. |
Lee SJ, Lee S. Toll-like receptors and inflammation in the CNS. Curr Drug Targets Inflamm Allergy, 2002, 1(2): 181-191.
|
6. |
Andersson A, Covacu R, Sunnemark D, et al. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol, 2008, 84(5): 1248-1255.
|
7. |
Isoda K, Young JL, Zirlik A, et al. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol, 2006, 26(3): 611-617.
|
8. |
Hyun B, Shin S, Lee A, et al. Metformin down-regulates TNF-α secretion via suppression of scavenger receptors in macrophages. Immune Netw, 2013, 13(4): 123-132.
|
9. |
张桂春, 孙丽娟, 张凌红, 等. 二甲双胍在小鼠体内的药动学和组织分布. 中国新药与临床杂志, 2008, 27(3): 175-179.
|
10. |
Zhao RR, Xu XC, Xu F, et, al. Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice. Biochem Biophys Res Commun, 2014, 448(4): 414-417.
|
11. |
Racine R, Okujava V, Chipashvili S. Modification of seizure activity by electrical stimulation mechanisms. Electroencephalogr Clin Neurophysiol, 1972, 32(3): 295–299.
|
12. |
Maguire M. The psychopharmacology of epilepsy. Handb Clin Neurol, 2019, 165: 207-227.
|
13. |
梁稀, 许虹, 李欣潞, 等. 抑郁和焦虑情绪在癫痫患者客观认知功能和主观记忆间的中介作用. 中华行为医学与脑科学杂志, 2021, 30(10): 898-903.
|
14. |
Plevin D, Smith N. Assessment and Management of Depression and Anxiety in Children and Adolescents with Epilepsy. Behav Neurol, 2019, 2: 2571368.
|
15. |
Mitchell S, Vargas J, Hoffmann A. Signaling via the NFκB system. Wiley Interdiscip Rev Syst Biol Med, 2016, 8(3): 227-41.
|
16. |
Yu Z, Jiang N, Su W, et al. Necroptosis: A Novel Pathway in Neuroinflammation. Front Pharmacol, 2021, 12: 701564.
|
17. |
甄凤亚, 王岚, 安翠霞. Toll样受体4与抑郁症. 中华行为医学与脑科学杂志, 2017, 26(8): 760-764.
|
18. |
叶嘉颖, 杨炼红. 癫痫患者血清高迁移率族蛋白1与TOLL样受体4的表达及影响因素. 中山大学学报(医学科学版), 2021, 42(6): 839-845.
|
19. |
Lv Z, Guo Y. Metformin and its benefits for various diseases. Front Endocrinol (Lausanne), 2020, 16(11): 191.
|
20. |
Wang YW, He SJ, Feng X, et al. Metformin: a review of its potential indications. Drug Des Devel Ther, 2017, 11: 2421-2429.
|
21. |
李爽, 陈欣, 胡岩芳, 等. 基于TLR4/NF-KB途径探讨二甲双胍对EAE小鼠Th17细胞反应及T细胞分化的作用机制. 免疫学杂志, 2021, 37(12): 1037-1044.
|